Skip to Content

Radioligand Therapy in Cancer

This special issue belongs to the section "Cancer Therapy".

Special Issue Information

Keywords

  • PSMA and SSTR targeting radiopharmaceuticals
  • old and novel targets for radioligand therapy
  • dosimetry
  • toxicity evaluation and reduction
  • machine learning and artificial intelligence in radionuclide therapy
  • novel radiopharmaceutical
  • regulatory aspects of radioligand therapy
  • patient selection optimization
  • radioligand therapy for neuroblastoma and other pediatric malignancies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Published Papers

XFacebookLinkedIn
Cancers - ISSN 2072-6694